Excel Industries Ltd

Business Overview

• Diversified chemical producer focusing on phosphorus derivatives, agrochemical intermediates, and specialty chemicals.
• Contract manufacturing drives growth via long-term agreements and higher-margin projects.
• Sites at Roha, Lote, Vizag enable diversified product and capacity expansion.
• Exports contributed Rs 223 Cr in the period.

Financial Highlights

• Standalone revenue 294 Cr, EBITDA 42 Cr, PAT 29 Cr.
• Standalone EBITDA margin 14.4%, PAT margin 9.9%.
• Consolidated revenue 293.8 Cr, EBITDA 42.4 Cr, PAT 29.5 Cr.
• Consolidated margins: EBITDA 14.4%, PAT 10.0%.

Operational Milestones

• Dedicated manufacturing project completed on 23 July 2026; capex Rs 40 Cr; trade advance Rs 25 Cr.
• Supports 5-year long-term supply agreement with leading specialty chemicals company.
• Lote expansion capex and capacity: 1,265 MTPA planned.
• R&D center operational in Mumbai.

Capex & Capital Allocation

• Capex guidance: Rs 200-300 Cr over next three years.
• Annual maintenance capex Rs 30-40 Cr.
• Trade advance from customer: Rs 25 Cr under long-term supply agreement.
• No debt/equity changes disclosed.

Strategy & Outlook

• Near-term demand challenges in Agrochemical Intermediates persist.
• Non-agro product groups expected to sustain growth.
• Dedicated manufacturing setup commissioned; higher volumes targeted under long-term specialty chemical supply agreement.
• Product launches planned in Biocides and Performance Solutions in FY27.
• Capex and sustainability focus: solar energy investments; wastewater treatment upgrades.
• Vizag capacity expansion and EC approvals; Mumbai R&D supports backward integration.

Risks & Mitigation

• Erratic monsoon impacts Agrochemical Intermediates demand.
• Raw material price volatility and supply disruptions persist.
• Diversified product portfolio cushions overall performance.
• Management signals agility in supply chain.

Governance & Leadership

• Executive leadership includes Ashwin C. Shroff, Ravi A. Shroff, and Pradeep Ghattu.
• No governance changes disclosed.

Record Date Details

• Record date 17 September 2026 for FY 2025-26 final dividend on equity shares, subject to AGM declaration.

AGM Details

• 65th AGM on 24 September 2026 at 3:00 PM via Video Conferencing/OAVM.

Voting Eligibility

• Cut-off for remote e-voting: 17 September 2026.

Financial Performance

• Consolidated unaudited Q1 FY27 results; quarter ended June 30, 2026.
• Revenue from operations Rs 29,383.09 lakhs; YoY -5%.
• Total income Rs 30,054.16 lakhs; YoY -6.6%.
• Profit before tax Rs 3,890.10 lakhs.
• Profit after tax Rs 2,946.65 lakhs; YoY -12.7%.
• EPS basic/diluted Rs 23.44; YoY -12.8%.
• Total comprehensive income Rs 17,217.56 lakhs.

Standalone results approved

• Unaudited standalone results for quarter ended June 30, 2026 approved.

Audit and consolidated results

• Audit Committee reviewed the results prior to Board approval.
• Consolidated interim results reviewed by auditors with unmodified opinion.
• Auditor: Price Waterhouse Chartered Accountants LLP.

Regulatory and segment notes

• Results prepared in Ind AS; compliant with SEBI LODR Regulation 33.
• Single reportable segment: Chemical.

Excel Industries Ltd – Trading window closed till 15 August 2026; reopens 16 August 2026 ahead of Q2/quarter ended 30 June 2026 unaudited results

Meeting Details

• Board meeting scheduled for 13 August 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited quarterly results for the quarter ended 30 June 2025.

Other Notes

• Trading window remains closed till 15 August 2026; reopens on 16 August 2026.

Nominee Director appointment

• Purpose: appoint Mr. Mahtabuzzaman as Nominee Director (Ordinary resolution).
• Outcome: Passed; 6,295,388 votes polled (50.08%), 6,295,204 in favour, 184 against.
• Record date: 5 June 2026; voting window: 15 June–14 July 2026.
• Promoter group not interested in the agenda.